Publications
The potential of in silico approaches to streamline drug development
This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug discovery, development, and delivery. It calls for adaptation of in silico technology to be a standard practice to complement in vivo and in vitro approaches in healthcare through a collaborative ecosystem of stakeholders.
The Role of Artificial Intelligence within In Silico Medicine
A range of authors across academia and industry, representing both the Avicenna Alliance and the Virtual Physiological Human Institute, have produced a new white paper on the potential of computer modelling and simulation in healthcare, with a particular focus on the role of Artificial Intelligence.
Toward a Regulatory Pathway for Using In Silico Trials in CE Marking Position Paper
A team of researchers of the In Silico World project, including several key Avicenna Alliance members, led by Prof. Francesco Pappalardo (University of Catania), Avicenna Alliance’ Pharmaceutical Strategy TF Co-Chair, recently published a Position Paper in IEEE Journal of Biomedical and Health Informatics (J-BHI).
Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!
On 22 June, a group of five Members of the European Parliament (MEPs) sent a letter to Commissioner for Health, Stella Kyriakides to call for action on computer modelling and simulation (CM&S).
The new Avicenna position paper on in silico evidence in the regulatory approval of medical devices is out!
The Avicenna Alliance is proud to announce the recent publication of its new position paper entitled Ensuring the Quality of in silico Evidence: Application to Medical Devices.
The new Avicenna flyer is out!
Avicenna Alliance has developed a brand-new Avicenna flyer for public distribution aiming at giving a concise overview of its origins, purpose, activities, mission, and long-term vision.
